Shubham Chamadia

Shubham Chamadia

Auto-generated profile, based on publicly available information

Shubham Chamadia

Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2017 in IEEE Transactions on Signal Processing
Verified
Journal Article
Open access
PMPanos P. Markopoulos
Panos P. Markopoulos
SKSandipan Kundu
Sandipan Kundu
SCShubham Chamadia
Shubham Chamadia
Dimitris PadosDimitris Pados
Dimitris Pados
It was shown recently that the K L1-norm principal components (L1-PCs) of a real-valued data matrix X ∈ R D×N (N data samples of D dimensions) can be exactly calculated with cost O(2 NK ) or, when advantageous, O(N dK - K + 1 ) where d=rank (X), K<;d. In applications where X is large (e.g., “big” data of large N and/or “heavy” data of large d), these costs are prohibitive. In this paper, we present a novel suboptimal algorithm for the calculation of the K <; d L1-PCs of X of cost O (ND min {N, D} + N 2 K 2 (K 2 + d)), which is comparable to that of standard L2-norm PC analysis. Our theoretical and experimental studies show that the proposed algorithm calculates the exact optimal L1-PCs with high frequency and achieves higher value in the L1-PC optimization metric than any known alternative algorithm of comparable computational cost. The superiority of the calculated L1-PCs over standard L2-PCs (singular vectors) in characterizing potentially faulty data/measurements is demonstrated with experiments in data dimensionality reduction and disease diagnosis from genomic data.

15 November 2019 in Communications Biology
Verified
Journal Article
Open access
PDF file
SCShubham Chamadia
Shubham Chamadia
JPJuan C. Pedemonte
Juan C. Pedemonte
EHEunice Y. Hahm
Eunice Y. Hahm
JMJennifer Mekonnen
Jennifer Mekonnen
RIReine Ibala
Reine Ibala
OAOluwaseun Akeju
Oluwaseun Akeju
Understanding anesthetic mechanisms with the goal of producing anesthetic states with limited systemic side effects is a major objective of neuroscience research in anesthesiology. Coherent frontal alpha oscillations have been postulated as a mechanism of sevoflurane general anesthesia. This postulate remains unproven. Therefore, we performed a single-site, randomized, cross-over, high-density electroencephalogram study of sevoflurane and sevoflurane-plus-ketamine general anesthesia in 12 healthy subjects. Data were analyzed with multitaper spectral, global coherence, cross-frequency coupling, and phase-dependent methods. Our results suggest that coherent alpha oscillations are not fundamental for maintaining sevoflurane general anesthesia. Taken together, our results suggest that subanesthetic and general anesthetic sevoflurane brain states emerge from impaired information processing instantiated by a delta-higher frequency phase-amplitude coupling syntax. These results provide fundamental new insights into the neural circuit mechanisms of sevoflurane anesthesia and suggest that anesthetic states may be produced by extracranial perturbations that cause delta-higher frequency phase-amplitude interactions.

24 March 2021 in Journal of Sleep Research
Verified
Journal Article
Closed access
PDF file
RIReine Ibala
Reine Ibala
JMJennifer Mekonnen
Jennifer Mekonnen
JGJacob Gitlin
Jacob Gitlin
EHEunice Y. Hahm
Eunice Y. Hahm
BEBreanna R. Ethridge
Breanna R. Ethridge
OAOluwaseun Akeju
Oluwaseun Akeju

18 August 2021 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
IGIndie C. Garwood
Indie C. Garwood
SCSourish Chakravarty
Sourish Chakravarty
JDJacob Donoghue
Jacob Donoghue
MMMeredith Mahnke
Meredith Mahnke
PKPegah Kahali
Pegah Kahali
EBEmery N. Brown
Emery N. Brown
Ketamine is an NMDA receptor antagonist commonly used to maintain general anesthesia. At anesthetic doses, ketamine causes high power gamma (25-50 Hz) oscillations alternating with slow-delta (0.1-4 Hz) oscillations. These dynamics are readily observed in local field potentials (LFPs) of non-human primates (NHPs) and electroencephalogram (EEG) recordings from human subjects. However, a detailed statistical analysis of these dynamics has not been reported. We characterize ketamine’s neural dynamics using a hidden Markov model (HMM). The HMM observations are sequences of spectral power in seven canonical frequency bands between 0 to 50 Hz, where power is averaged within each band and scaled between 0 and 1. We model the observations as realizations of multivariate beta probability distributions that depend on a discrete-valued latent state process whose state transitions obey Markov dynamics. Using an expectation-maximization algorithm, we fit this beta-HMM to LFP recordings from 2 NHPs, and separately, to EEG recordings from 9 human subjects who received anesthetic doses of ketamine. Our beta-HMM framework provides a useful tool for experimental data analysis. Together, the estimated beta-HMM parameters and optimal state trajectory revealed an alternating pattern of states characterized primarily by gamma and slow-delta activities. The mean duration of the gamma activity was 2.2s([1.7,2.8]s) and 1.2s([0.9,1.5]s) for the two NHPs, and 2.5s([1.7,3.6]s) for the human subjects. The mean duration of the slow-delta activity was 1.6s([1.2,2.0]s) and 1.0s([0.8,1.2]s) for the two NHPs, and 1.8s([1.3,2.4]s) for the human subjects. Our characterizations of the alternating gamma slow-delta activities revealed five sub-states that show regular sequential transitions. These quantitative insights can inform the development of rhythm-generating neuronal circuit models that give mechanistic insights into this phenomenon and how ketamine produces altered states of arousal.

8 October 2021 in Clinical Neurophysiology
Verified
Journal Article
Closed access
SCShubham Chamadia
Shubham Chamadia
JGJacob Gitlin
Jacob Gitlin
JMJennifer Mekonnen
Jennifer Mekonnen
BEBreanna R. Ethridge
Breanna R. Ethridge
RIReine Ibala
Reine Ibala
OAOluwaseun Akeju
Oluwaseun Akeju

29 July 2020 in Journal of Neural Engineering
Verified
Journal Article
Closed access
KKKimia Kashkooli
Kimia Kashkooli
SPSam L Polk
Sam L Polk
EHEunice Y Hahm
Eunice Y Hahm
James MurphyJames Murphy
James Murphy
BEBreanna R Ethridge
Breanna R Ethridge
SCShubham Chamadia
Shubham Chamadia
Objective. The ability to monitor anesthetic states using automated approaches is expected to reduce inaccurate drug dosing and side-effects. Commercially available anesthetic state monitors perform poorly when ketamine is administered as an anesthetic-analgesic adjunct. Poor performance is likely because the models underlying these monitors are not optimized for the electroencephalogram (EEG) oscillations that are unique to the co-administration of ketamine. Approach. In this work, we designed two k -nearest neighbors algorithms for anesthetic state prediction. Main results. The first algorithm was trained only on sevoflurane EEG data, making it sevoflurane-specific. This algorithm enabled discrimination of the sevoflurane general anesthesia (GA) state from sedated and awake states (true positive rate = 0.87, [95% CI, 0.76, 0.97]). However, it did not enable discrimination of the sevoflurane- plus -ketamine GA state from sedated and awake states (true positive rate = 0.43, [0.19, 0.67]). In our second algorithm, we implemented a cross drug training paradigm by including both sevoflurane and sevoflurane- plus -ketamine EEG data in our training set. This algorithm enabled discrimination of the sevoflurane- plus -ketamine GA state from sedated and awake states (true positive rate = 0.91, [0.84, 0.98]). Significance. Instead of a one-algorithm-fits-all-drugs approach to anesthetic state monitoring, our results suggest that drug-specific models are necessary to improve the performance of automated anesthetic state monitors.